Introduction
============

Overweight and obesity are associated with a range of chronic disease states, including cardiovascular disease (CVD), type 2 diabetes and certain cancers. The World Health Organisation has estimated that around a third of coronary heart disease and ischaemic stroke cases are attributable to excess adiposity.^[@bib1]^ Current prevalence of overweight and obesity therefore has significant implications for population morbidity and mortality, and in this regard the rising prevalence of childhood obesity is of particular concern. In the United Kingdom, 2004 figures showed the prevalence of obesity in children aged 5--17 years to be 29%,^[@bib2]^ and most estimates suggest a doubling in prevalence over the course of the preceding decade.^[@bib3],\ [@bib4]^ Similarly in the United States, 32% of children and adolescents were observed to be at or above the 85th percentile of the 2000 body mass index (BMI)-for-age growth charts.^[@bib5],\ [@bib6]^ Such data are predictive of adult overweight and obesity rates in the future, as adiposity has been shown to track from childhood into adult life.^[@bib7],\ [@bib8]^ It is generally assumed that an earlier onset and longer duration of obesity is associated with a greater cardiovascular risk, increasing concern about childhood obesity trends.

Although many studies have demonstrated positive associations between childhood obesity and adult cardiovascular risk, important questions remain as to the nature of the relationship.^[@bib9]^ For example, it is not clear whether weight loss interventions in adult life can fully ameliorate the risks associated with childhood obesity, or whether an independent effect of childhood obesity remains, irrespective of the degree of adult adiposity. This has major implications for the design and timing of appropriate public health interventions. Our recent systematic review suggested that the observed associations between childhood obesity and adult blood pressure, carotid intima--media thickness or cardiovascular events largely reflected the tracking of BMI from childhood into adult life, and concluded that there was little evidence of an association that was independent of adult BMI.^[@bib10]^ The data suggested that avoiding overweight during childhood failed to provide any protection against the effects of obesity in adulthood, and that those who were obese children but went on to be normal weight adults were not at any greater risk of CVD. Interestingly, those who were lean as children seemed to be most susceptible to the risks associated with adult obesity, particularly with respect to high blood pressure. Lauer *et al.*^[@bib11]^ also observed that the strongest predictor of blood pressure was a change from being at the lower end of the BMI scale in children to the higher end in adulthood. Li *et al.*^[@bib12]^ reported that the effect of adult BMI on blood pressure was highest in those who had been in the lowest BMI decile as children. These associations remain unexplained, but may reflect the differing contributions of lean body mass to BMI across the lifespan and the cumulative effect of changes in body composition over time. The nature of these observations indicates a complexity in the relationship between obesity and metabolic risk across the lifespan, which is worthy of further study.

This second systematic review builds upon that published previously, with the aim of assessing the relationship between childhood obesity and a range of metabolic risk factors related to cardiovascular health during adult life. The inclusion criteria for this review focused on the selection of studies focusing on the wider components of the metabolic syndrome, including dyslipidaemia, insulin resistance and metabolic disease outcomes. This has enabled more detailed investigation of the important research questions regarding the long-term impact of childhood obesity, which arose from the previous review.

Materials and methods
=====================

The general methods of systematic review used in this study were as previously described in Lloyd *et al.*^[@bib10]^ Briefly, we reviewed the literature reporting results from longitudinal studies investigating the association between childhood obesity and adult metabolic disease risk. A computerised search of the online electronic databases PubMed (MEDLINE) and ISI Web of Science from inception up to 30 June 2010 was carried out, using the terms 'childhood\', 'adult\' and 'obesity\'. The selection process and number of articles excluded at each stage are shown in [Figure 1](#fig1){ref-type="fig"}.

Two investigators (LJL and SM) independently reviewed studies for eligibility according to the criteria below. Agreement was good (*κ*=99%) and any differences were agreed by consensus.

The inclusion criteria were as follows: Childhood measures of BMI at one or more ages in childhood (0--12) or adolescence.^[@bib13],\ [@bib14],\ [@bib15],\ [@bib16],\ [@bib17],\ [@bib18]^ All measurements taken by health professionals or trained investigators.Childhood BMI status calculated using US Centre for Disease Control percentile charts^[@bib5]^ or International Obesity Task Force charts,^[@bib13]^ and childhood overweight and obese defined as within those criteria (Centre for Disease Control: \>85th centile=at risk of overweight, \>95th centile=overweight; International Obesity Task Force percentiles track back from World Health Organisation adult guidelines^[@bib14]^ of ⩾25 kg m^−2^ overweight and ⩾30 kg m^−2^ obese). Or childhood BMI treated as a continuous variable and association with adult outcome assessed by regression or correlation.Adult overweight and obese defined according to World Health Organisation guidelines^[@bib14]^ as overweight when BMI ⩾25 kg m^−2^ and obese when BMI ⩾30 kg m^−2^.One or more biomarkers of metabolic disease risk measured at one or more ages in adulthood (defined as \>18 years of age), for example, cholesterol, triglycerides and plasma insulin. All measurements were taken by health professionals or trained investigators. Or metabolic disease outcomes/cause of death extracted from secure registers.Studies carried out in westernised, developed countries.Articles in English language.

The exclusion criteria were as follows: Studies where participants were part of an obesity intervention/health promotion programme.Studies where the individuals involved were all part of a selected group, for example, asthmatics, childhood cancer survivors, preterm babies, and so on.Studies in which exposure or outcome had been self-reported.Childhood or adult overweight/obese defined using arbitrary cutoff points.Reviews, rather than original data.

Data extraction and quality assessment
--------------------------------------

Data were extracted as described previously.^[@bib10]^ In short, regression or correlation coefficients, or hazard ratios or relative risks and confidence intervals were extracted, together with the statistical significance of the associations (where provided). These data are summarised in [Table 1](#tbl1){ref-type="table"}.

Quality of the papers that passed the defined criteria for inclusion in the review was assessed using the Newcastle--Ottawa Scale, based on recommendations by the Cochrane Non-Randomised Studies Methods Working group, as described previously.^[@bib10]^ Two investigators (LJL and SM) independently assessed study quality according to the criteria in [Table 2](#tbl2){ref-type="table"}. Agreement was good (*κ*=91.4%) and differences were agreed by consensus. Results from the quality assessment are summarised in [Table 3](#tbl3){ref-type="table"}.

Results
=======

In all, 11 articles fulfilled the selection criteria and a summary of the main characteristics and results is shown in [Table 1](#tbl1){ref-type="table"}. All studies, apart from one, were published in the last 10 years.

Quality assessment
------------------

Although a satisfactory degree of quality had been assured through the inclusion/exclusion criteria, there was still some variation between the quality assessments made using the Newcastle--Ottawa Scale ([Table 3](#tbl3){ref-type="table"}). Based on sample selection, all studies were rated highly with one study attaining four out of four possible stars^[@bib15]^ and all others attaining three, apart from Thearle *et al.*,^[@bib16]^ which fulfilled only two of the quality criteria. The studies with three stars all failed to show the absence of the outcome of interest in childhood. Thearle *et al.*^[@bib16]^ studied Pima Indians, therefore failing to attain a star for being truly representative of a westernised cohort. For comparability there was more variation, with only one study^[@bib17]^ attaining both of the available stars, six rated one star, three no stars and one study^[@bib18]^ providing insufficient information to make an assessment. This variation was due to differences in accounting for confounding factors ([Table 2](#tbl2){ref-type="table"}). Age and gender were generally accounted for, but other confounding factors such as smoking or socioeconomic status were unaccounted for in most of the studies. Crucially, only four studies adjusted for current BMI or adult percentage body fat, and as a result the majority of studies was unable to draw valid conclusions regarding the independent impact of childhood obesity upon metabolic parameters.^[@bib16],\ [@bib17],\ [@bib19],\ [@bib20]^ For assessment, seven studies attained two stars and four studies rated three. Of those that attained two, all were not awarded the third star because the adult cohort was considered too young (under 35) for the outcome to be demonstrated adequately.

It was difficult to directly compare results across the studies owing to the variety of statistical methods and approaches used and this was the primary reason for not performing a meta-analysis. Where relevant, regression coefficients, odds ratios or estimates of relative risk were extracted from the studies. Most studies treated childhood BMI as a continuous variable for the purpose of statistical analysis, but some used cutoff points (those recommended by US Centre for Disease Control^[@bib5]^ or International Obesity Task Force^[@bib13]^) to define childhood overweight or obese. In addition, childhood BMI scores were sometimes presented as *z*-scores, or as the change in BMI or BMI *z*-scores between age categories.

The exposure variable (childhood BMI) was also measured at substantially different ages, ranging from 2 to 18 years of age between studies. The age at which adult outcomes were measured also varied widely from 18 to 71 years, with historical cohort studies^[@bib21]^ tending to include adult outcomes at older ages than prospective studies. The year of birth in the studies ranged from the 1930s^[@bib21]^ up to the 1970s.^[@bib22],\ [@bib23],\ [@bib24]^ Some studies used one measure of childhood BMI, whereas others used longitudinal data from the same study participants, and thus had more than one BMI measure in childhood for each individual.

Generally the adult outcomes were more homogenous, with total cholesterol, triglycerides and high-density lipoprotein (HDL)-cholesterol being measured by standard chemical and/or enzymatic procedures as described in the Lipid Research Clinics Program Manual of Laboratory Operations^[@bib25]^ or by Lamont *et al.*^[@bib26]^ low-density protein (LDL)-cholesterol was calculated using the Friedewald equation.^[@bib27]^ Fasting insulin was measured using standard radioimmunoassay kits. To determine insulin resistance, Martin *et al.*^[@bib21]^ calculated homeostasis model assessment (HOMA), and Thearle *et al.*^[@bib16]^ calculated acute insulin response and insulin action. Definitions of metabolic syndrome varied between studies. Srinivasan and co-workers^[@bib15]^ defined those at risk of syndrome X as being those individuals with the highest quartiles of BMI, blood pressure, fasting insulin and total cholesterol:HDL-cholesterol or triglycerides:HDL-cholesterol ratios. Morrison *et al.*^[@bib28]^ used the definition of metabolic syndrome as described by the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults.^[@bib29]^ Salonen *et al.*^[@bib17]^ used the criteria defined by the International Diabetes Federation 2005. Mortality and morbidity outcomes were identified from the Cause of Death Registry at Statistics Norway.^[@bib22]^

Main results
------------

### Total cholesterol

Four studies considered the impact of childhood BMI on adult total cholesterol concentrations ([Table 1](#tbl1){ref-type="table"}), with two studies^[@bib19],\ [@bib23]^ showing weak to moderate positive correlations. One study^[@bib20]^ reported a negative correlation between BMI at age 9 and cholesterol in women in adulthood, but no significant correlation with BMI at age 13 (no correlation observed in men at either age). Sinaiko *et al.*^[@bib24]^ showed no statistically significant association.

All four studies observed significant tracking of childhood BMI into adulthood, but two studies^[@bib23],\ [@bib24]^ did not adjust for adult BMI, thus the independent effects of childhood BMI were not investigated. Of the two studies that did adjust for adult BMI, Freedman *et al.*^[@bib19]^ reported a weak, negative correlation between the two variables after adjustment and Wright *et al.*^[@bib20]^ observed that the weak negative correlation between total cholesterol and BMI at age 9 in women persisted.

### LDL- and HDL-cholesterol

Three of the four studies mentioned above also looked at LDL- and HDL-cholesterol concentrations.^[@bib19],\ [@bib20],\ [@bib24]^ Freedman *et al.*^[@bib19]^ showed a weak positive correlation between childhood BMI and adult LDL-cholesterol, but this became negative once adjusted for adult BMI. They also reported the opposite for HDL-cholesterol, that is, a weak negative correlation, which became positive once adjusted for adult BMI. The two other studies^[@bib20],\ [@bib24]^ did not show any significant correlations between childhood BMI and LDL-cholesterol, and this was still the case after adjustment for adult BMI in the Wright *et al.* study.^[@bib20]^ Wright *et al.* reported the same findings regarding HDL-cholesterol, that is, no significant correlation between childhood BMI and HDL-cholesterol before or after adjusting for adult BMI. Sinaiko *et al.*^[@bib24]^ did show a significant but weakly negative correlation between childhood BMI and HDL-cholesterol, but did not adjust for adult BMI. This study was rated poorly in the quality assessment ([Table 3](#tbl3){ref-type="table"}). Salonen *et al.*^[@bib17]^ included data for HDL-cholesterol as part of defining the metabolic syndrome, but reported no significant correlations between childhood BMI at any age and adult HDL-cholesterol. However, it was not clear if this was adjusted for adult percentage body fat or not.

### Triglycerides

Two studies^[@bib19],\ [@bib24]^ reported positive correlations between childhood BMI and adult triglyceride concentrations. One of these^[@bib24]^ did not adjust for adult BMI despite observing significant tracking of BMI into adulthood, hence the independent effects of childhood BMI were not investigated. Freedman *et al.*^[@bib19]^ did adjust for adult BMI and found the relationship inversed, that is, that a greater childhood BMI was associated with lower circulating triglyceride concentrations in adulthood. Another study^[@bib17]^ reported no significant correlation between the two variables, although it was not clear if this was adjusted for adult body fat. Conversely, Wright *et al.*^[@bib20]^ reported a weak negative correlation between childhood BMI at age 9 and adult triglyceride concentrations in women, which became stronger once adjusted for current BMI. However, no such associations were seen at age 13, or at either time point for males.

### Insulin

Six studies considered the impact of childhood BMI on adult insulin concentrations or insulin resistance. Three studies^[@bib18],\ [@bib19],\ [@bib24]^ reported moderate positive correlations between childhood BMI and insulin concentrations. However, the adjusted data set for Freedman *et al.*^[@bib19]^ showed that this association became negative once adjusted for current BMI. The second paper by Freedman *et al.*^[@bib18]^ did not report whether or not the data were adjusted for adult BMI. Sinaiko *et al.*^[@bib24]^ did not make the adjustment, thus the independent effects of childhood BMI were not assessed. Thearle *et al.*^[@bib16]^ reported moderate positive correlations between childhood BMI and adult acute insulin response and adult insulin action, which were adjusted for adult percentage body fat, therefore supporting an independent effect of childhood BMI on these variables.

Interestingly, the two studies with the oldest adult cohorts had contrasting findings to the literature relating to younger populations. Wright *et al.*^[@bib20]^ observed no significant correlations between childhood BMI and adult insulin concentrations, but a significant negative correlation became apparent once adjusted for adult BMI. Martin *et al.*^[@bib21]^ reported a significantly lower homeostasis model assessment-insulin resistance in adults who were of greater BMI during childhood. Homeostasis model assessment-insulin resistance fell by 8% per standard deviation of increasing childhood BMI. This study reported that the heaviest children were least likely to manifest as insulin resistant in adulthood. This tendency was particularly marked among children who went on to become lean adults.

### Disease outcomes

Four studies considered the impact of childhood BMI on risk of type 2 diabetes and metabolic syndrome in adulthood. Two studies showed positive correlations between disease outcomes and childhood BMI. Srinivasan *et al.*^[@bib15]^ observed a positive relationship between childhood BMI and the number of metabolic syndrome criteria risk variables in adulthood. Morrison *et al.*^[@bib28]^ reported that for every one unit increase in childhood BMI percentile, the odds ratio for developing the metabolic syndrome in adulthood was 1.025. The other two studies had the oldest adult cohorts. Bjorge *et al.*^[@bib22]^ reported no significant increase in risk of death from type 2 diabetes in men associated with childhood obesity. It did not report results for women. The final study by Salonen *et al.*^[@bib17]^ reported that higher childhood BMI was associated with lower risk of metabolic syndrome in adult life. This was the only one of the four diabetes studies that adjusted for adult adiposity, thus independent effects of childhood BMI were not considered by most of the studies in this area.

Discussion
==========

In developed countries, circulatory disease is the most common cause of death, accounting for 33% of UK deaths in 2008,^[@bib30]^ and in Europe 48% of deaths are due to CVD.^[@bib2]^ The burden of disease is increasing owing to ageing populations and the rising prevalence of obesity and its associated co-morbidities. It is imperative to understand how events at important stages across the lifespan influence long-term risk of disease, so that interventions can be targeted to the most appropriate time point. There is a widely held assumption that childhood obesity is an independent risk factor for adult metabolic and CVD. However, our previous review indicated that the relationships are largely dependent on the tracking of BMI from childhood to adulthood. Importantly, the evidence suggested that the risk of raised blood pressure was highest in those who were at the *lower* end of the BMI scale in childhood and overweight in adulthood. The current review has extended these findings to investigate the relationship between childhood obesity and a range of metabolic risk factors. Using an unbiased review methodology, we found insufficient evidence to support the idea that childhood obesity independently increases risk of dyslipidaemia and insulin resistance in adulthood. Conversely, and in support of our previous analysis of blood pressure data, the review demonstrates that those who were lean as children seemed to be most susceptible to the metabolic risk associated with adult obesity.

Our previous review^[@bib10]^ focused on studies assessing CVD end points and two major clinical risk factors for CVD, blood pressure and carotid intima--media thickness. The quality assessment of the studies included raised significant issues regarding the quality of the data presented. In particular, the studies assessing CVD end points were all retrospective in nature, focused on non-contemporary populations and failed to adjust for adult BMI. In contrast, the studies assessing blood pressure and carotid intima--media thickness were more likely to have adjusted for adult BMI, but often involved adult cohorts with an average age considered too young for the outcome to be assessed adequately. The current review aimed to overcome these limitations to some extent by assessing a range of intermediary risk factors.

Blood lipids
------------

Dyslipidaemia is a widely recognised risk factor for progression of atherosclerosis,^[@bib31]^ and is a component of the metabolic syndrome and CVD. Adult obesity is generally associated with dyslipidaemia and recent literature suggests that the origins of dyslipidaemia may be determined in childhood, in conjunction with obesity. Several studies have demonstrated links between childhood obesity and raised total cholesterol, LDL-cholesterol, triglycerides and low HDL-cholesterol concentrations^[@bib32],\ [@bib33]^ in adulthood. Importantly, blood lipid concentrations have been shown to track from childhood to adulthood.^[@bib34]^

This review demonstrates an overwhelming lack of evidence of an *independent* positive relationship between childhood BMI and dyslipidemia. Of the two studies that reported positive associations between childhood BMI and adult total cholesterol,^[@bib19],\ [@bib23]^ only one adjusted for adult BMI, and doing so reversed the direction of the relationship,^[@bib19]^ suggesting that those with higher BMI in childhood had lower total cholesterol in adulthood if overweight was not maintained. An inverse association after adjustment for adult BMI was also observed in women in the study by Wright *et al.*^[@bib20]^ Lauer *et al.*^[@bib23]^ showed the strongest positive association between childhood BMI and adult cholesterol, but the data were not adjusted for adult BMI, despite a strong degree of tracking of BMI from childhood into adulthood (*r*=0.53--0.84). Similarly for LDL-cholesterol, the positive association with childhood BMI reported by Freedman *et al.*^[@bib19]^ became negative after adjustment for adult BMI, suggesting that those with higher BMI in childhood had lower LDL-cholesterol as adults if overweight was not maintained. Negative correlations between childhood BMI and HDL-cholesterol were reported by two studies. Once again, adjustment for adult BMI in the Bogalusa Heart Study rendered this relationship positive,^[@bib19]^ while the other study demonstrated a high degree of BMI tracking into adulthood (*r*=0.612), but did not make the adjustment.^[@bib24]^ Similar themes emerged in consideration of associations between adult triglyceride concentrations and childhood BMI, with negative association observed in the two studies that made the adjustment for adult BMI.

Our review therefore found very little evidence to suggest that greater BMI in childhood was an independent risk factor for dyslipidaemia in adulthood. This is in agreement with the findings of Porkka *et al.*,^[@bib35]^ who reported that childhood obesity variables (BMI and subscapular skinfold) were poor predictors of adult serum levels and only accounted for between 0 and 6% of adult lipid variability. In contrast to commonly held assumptions and in agreement with our previous review of blood pressure data, several studies observed that those who had a *higher* BMI during childhood exhibited *lower* total cholesterol, LDL-cholesterol and triglycerides and *higher* HDL-cholesterol.

Insulin
-------

Increased adiposity generally leads to systemic hyperinsulinaemia and decreased skeletal muscle sensitivity.^[@bib36]^ Insulin resistance is linked to a range of comorbidities, including obesity, dyslipidaemia, type 2 diabetes and atherosclerotic disease.^[@bib37],\ [@bib38]^ Obese children have higher fasting insulin and homeostasis model assessment-insulin resistance compared with age-matched lean children.^[@bib39],\ [@bib40]^ Clinically relevant morbidities, however, remain unusual in children and adolescents.^[@bib41]^ Of the six studies that met the selection criteria for this review, three^[@bib18],\ [@bib19],\ [@bib24]^ reported moderate positive correlations between childhood BMI and adult insulin concentrations. However, only one of these adjusted for adult BMI and this reversed the direction of the association observed, similar to the patterns observed in the blood lipid data. The only study in support of an association that is independent of adult BMI was that by Thearle *et al.*,^[@bib16]^ who reported a positive correlation between childhood BMI and acute insulin response (and a negative correlation with insulin action) when adjusted for adult percentage body fat. Generally, the positive associations between childhood BMI and insulin were slightly stronger than those for blood lipids (range *r*=+0.26 to +0.36). Although the clinical significance of these trends may not be great, this may indicate a slightly stronger correlation between adult BMI and insulin than that between adult BMI and blood lipids. However, it must be noted that such an assertion is dependent on the studies noted to be of lower quality in this review. The Thearle study^[@bib16]^ had some important limitations when considering its relevance to a wider population, as the cohort was very small (*n*=76) and limited to Pima Indians, a group known to be particularly susceptible to type 2 diabetes.

Interesting negative associations were observed in two other studies. Martin *et al.*^[@bib21]^ reported that the heaviest children were least likely to manifest as insulin resistant in adulthood, particularly if they went on to be lean. Wright *et al.*^[@bib20]^ reported a negative association between childhood BMI and insulin after adjustment for adult BMI. Although study design and paucity of data made it difficult to draw firm conclusions, the balance of available material does not provide sufficient evidence to support an independent detrimental effect of childhood obesity on adult insulin status. Similarly to blood lipids, the data may instead indicate that those who are heavier as children may be less likely to exhibit insulin resistance as adults. We suggest that this may relate to the greater contribution of lean mass to weight and BMI during childhood, and its subsequent involvement in regulating insulin sensitivity.

Disease outcomes
----------------

To extend the findings of our previous review of CVD outcomes, the current review assessed the relationship between childhood obesity and risk of metabolic syndrome and type 2 diabetes. The International Diabetes Federation estimates that 285 million people worldwide have diabetes in 2010 and this will rise to 438 million by 2030.^[@bib42]^ A similar pattern is envisaged in the United Kingdom, with 2.6 million people diagnosed in 2009, rising to over 4 million by 2025.^[@bib43]^ Around 80% of those adults with type 2 diabetes also fulfil the criteria for metabolic syndrome.^[@bib44]^

Within the studies that met the inclusion criteria for this review, evidence was presented of a positive correlation between childhood BMI and the number of metabolic syndrome criteria risk variables^[@bib15]^ and risk of developing the metabolic syndrome.^[@bib28]^ In contrast, Salonen *et al.*^[@bib17]^ reported a *decreased* risk of metabolic syndrome for those with the highest childhood BMI and the largest study,^[@bib22]^ which included over 225 000 subjects, found childhood BMI was not linked to increased risk of type 2 diabetes mortality in men. Taken together, these data fail to provide clear evidence that high childhood BMI leads to increased risk of diabetes and metabolic system morbidity or mortality. Few studies have tested the hypothesis directly and weaknesses were identified in those that did. For example, Morrison *et al.*^[@bib28]^ relied on self-reports of the presence of type 2 diabetes, which may have been associated with under-reporting.

Final conclusions
-----------------

To conclude, this systematic review has found little evidence to support the view that childhood obesity is an independent risk factor for adult blood lipid status, insulin levels, metabolic syndrome or type 2 diabetes. The research for each is generally insufficient, with the majority of studies failing to adjust for adult BMI and therefore not able to assess the relationship independently of the tracking of BMI and associated biomarkers of metabolic disease across the lifespan. The study by Must *et al.*^[@bib45]^ is often cited as demonstrating a link between adolescent obesity and long-term mortality and morbidity that is independent of adult BMI. However, this study did not meet the criteria for inclusion within this review owing to the use of arbitrary cutoffs for categorising overweight. In addition, the lean cohort only covered a small range at the lower end of what is currently considered to be normal weight and cannot be considered representative of contemporary populations. This systematic review provides a balanced summary of the available data and concludes that there is insufficient evidence to demonstrate links with long-term risk, which are independent of adult BMI.

Interestingly, for those studies that did adjust for adult BMI, the balance of data suggest that there is a weak *negative* association between childhood obesity and metabolic variables, which could be interpreted as a slight protective effect of obesity in childhood. Similar observations were observed with regard to adult blood pressure in our previous review. However, BMI is a measure of weight relative to height rather than actual adiposity, and fat-free mass makes up a higher proportion of BMI than fat mass in childhood compared with adulthood.^[@bib46]^ Relatively weak correlations between BMI and percentage body fat have been observed in children and adolescents.^[@bib47],\ [@bib48],\ [@bib49],\ [@bib50]^ Differences in BMI may therefore reflect differences in fat-free mass, particularly among those at the lower end of the BMI range.^[@bib48]^ These observations make the negative associations between childhood BMI and adult metabolic risk (independent of adult BMI) particularly interesting, as they may reflect the long-term consequences of differences in the trajectory of lean mass deposition from as early as childhood. More detailed study of the impact of the trajectory of both fat and fat-free mass on future metabolic and cardiovascular risk is required to address this issue. The impact of diet and body composition during the developmental period on long-term metabolic function and disease risk has been demonstrated in a range of epidemiological studies, with biological plausibility and causality demonstrated in experimental studies in animal models.^[@bib51]^ We suggest that the susceptibility of long-term metabolic function to diet and body composition extends throughout the growth phase, and that the pattern of inverse associations, which has emerged from this systematic review, may reflect the impact of 'mismatch\' between the growth phase and adult periods of the life course. Further work is required to establish which physiological systems remain sensitive to permanent change and to identify a threshold age below which the inverse associations arise.

There is substantial evidence that childhood obesity tracks into adulthood and it is clear that adult obesity conveys higher risk of metabolic disease. We are not, therefore, suggesting that childhood obesity is without consequences. Targeting childhood and adolescence for prevention and treatment of obesity is wholly appropriate to establish a healthy weight moving forward into the adult years. However, it is evident from this systematic review that the nature of the relationship between early BMI and adult disease risk is very complex. Those who are at the lower end of the BMI range in childhood, but go on to be obese during adulthood seem to be at particular risk. Focusing on children who are overweight or obese for the promotion of healthy weight management may therefore miss an important at-risk group.
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###### Characteristics of the selected studies grouped by outcome measurement

  *References*                           *Childhood age (years)*        *Adult age (years)*  *Population*                                                                   n               *Tracking of BMI*           *Effect size and significance*                                                                                                                                                                                             *Effect of adjusting for adult BMI/% body fat*
  -------------------------------- ----------------------------------- --------------------- -------------------------------------------------------------------------- --------- ------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Blood lipids*                                                                                                                                                                                                                                                                                                                                                                                                                                   
   Freedman *et al.*^[@bib19]^                    5--17                       18--37         Males and females in Louisiana, USA, born 1959--1968; BHS                    2617                  *r*=0.58                Cholesterol *r*=+0.10^\*^ Triglycerides *r* =+0.16^\*^ LDL *r*=+0.11^\*^ HDL *r*=−0.14^\*^                                                                                                                                 Relationships inversed Cholesterol *r*=−0.08 Triglycerides *r*=−0.09 LDL *r*=−0.09 HDL *r*=+0.07
   Salonen *et al.*^[@bib17]^                     0--11                      Mean 61.5       Males and females in Helsinki, Finland, born 1934--1944                       499                Not reported              HDL---NS Triglycerides---NS                                                                                                                                                                                                Not reported
   Sinaiko *et al.*^[@bib24]^                     7--18                         23           Males and females in Minneapolis, USA, born 1970--71 MCBPS                    679               *r*=0.612^\*\*^            Cholesterol---NS Triglycerides *r*=+0.19^\*\*^ LDL NS HDL *r*=−0.18^\*\*^                                                                                                                                                  Not adjusted
   Wright *et* *al.*^[@bib20]^                    9, 13                         50           Males and females in Newcastle, UK, born 1947 NTFS                            412               *r*=0.24-- 0.39            All blood lipids NS for men Women---age 13 all blood lipids NS  age 9, Cholesterol *r*=−0.15^\*^  age 9, triglycerides *r*=−0.18^\*^  age 9, LDL and HDL NS                                                                Men: age 9, triglycerides *r*=−0.18^\*^ Women: age 9, cholesterol *r*=−0.17^\*^ triglycerides *r*=−0.27^\*^ age 13, triglycerides *r*=−0.19 All other ages/variables NS
   Lauer *et al.*^[@bib23]^                       8--18                       20--30         Males and females in Iowa, USA, born 1960--70s                               2446             *r*=0.53-- 0.84^\*^          Change in cholesterol with change in BMI: Men *r*=0.20--0.45^\*^ Women *r*=0.10--0.26^\*^ from ages 11+, but NS at ages 7--10                                                                                              Not adjusted
                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  *Insulin*                                                                                                                                                                                                                                                                                                                                                                                                                                        
   Freedman *et al.*^[@bib19]^                    5--17                       18--37         Males and females in Louisiana, USA, born 1959--1968; BHS                    2617                  *r*=0.58                *r*=0.26^\*^                                                                                                                                                                                                               *r*=−0.15^\*^
   Freedman *et al.*^[@bib18]^                    3--17                       Mean 27        Males and females in Louisiana, USA, born 1959--1968; BHS                    2911     *r*=0.58[b](#t1-fn3){ref-type="fn"}  Age 3--7, *r*=+0.27 Age 8--13, *r*=+0.31 Age 14--17, *r*=+0.36                                                                                                                                                             Not adjusted
   Martin *et al.*^[@bib21]^                     Mean 6                       Mean 71        Males and females, England and Scotland, born 1920s and 1930s                 456                  *r*=0.12                HOMA −8.0% (CI −0.2 to −15.1) per s.d. change in BMI in childhood                                                                                                                                                          Not adjusted
   Sinaiko *et al.*^[@bib24]^                     7--18                         23           Males and females in Minneapolis, USA, born 1970--1971 MCBPS                  679               *r*=0.612^\*\*^            *r*=+0.28^\*\*^                                                                                                                                                                                                            Not adjusted
   Thearle *et al.*^[@bib16]^                     5--16                       Mean 25        Males and females in Gila River Indian Community, USA, born 1960 onwards      76                 Not reported              Only adjusted figures reported                                                                                                                                                                                             Insulin action *r*=−0.43^\*\*^ Acute insulin response *r*=0.32^\*\*\*^ A 5 kg m^−2^ increase in childhood BMI =−7.4% (CI −12.7 to −1.8%) insulin action^\*^
   Wright *et* *al*.^[@bib20]^                    9, 13                         50           Males and females in Newcastle, UK, born 1947 NTFS                            412               *r*=0.24-- 0.39            NS                                                                                                                                                                                                                         Men: age 9, *r*=−0.17^\*\*\*^; Age 13, *r*=−0.23^\*\*\*^ Women: age 9, *r*=0.20^\*\*\*^; age 13 *r*=−0.21^\*\*\*^
                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  *Disease outcomes*                                                                                                                                                                                                                                                                                                                                                                                                                               
   Bjorge *et al.*^[@bib22]^        14--19[a](#t1-fn2){ref-type="fn"}        Up to 62        Males and females in Norway, born 1944--1961                                226 678              Not measured              Risk of death from diabetes mellitus Men : NS Women: results not reported                                                                                                                                                  Not adjusted
   Morrison *et al.*^[@bib28]^                  Mean 12.8                    Mean 38.4       Males and females, Princeton, USA, born 1960s                                 814                    0.59                  For every 1 point change in childhood BMI percentile, the OR for having metabolic syndrome was 1.025 (CI 1.018--1.033)                                                                                                     Not adjusted
   Salonen *et al.*^[@bib17]^                     0--11                      Mean 61.5       Males and females in Helsinki, Finland, born 1934--1944                       499                Not reported              Higher BMI associated with decreased risk of metabolic syndrome for ages 2--11 OR for having metabolic syndrome for every 1 s.d. change in BMI between ages: 0--2: 0.72 (CI 0.57--0.92) 2--7: 0.63 (0.49 0.81) 7--11: NS   OR for having metabolic syndrome for every 1 s.d. change in BMI between ages: 0--2: 0.75 (CI 0.59--0.95) 2--7: 0.63 (0.49 0.81) 7--11: NS
   Srinivasan *et al.*^[@bib15]^                  8--17                       19--38         Males and females in Louisiana, USA, born 1959--1968; BHS                     745     *r*=0.58[b](#t1-fn3){ref-type="fn"}  For every 1 s.d. change in childhood BMI, the OR for having clustering of risk variables for metabolic syndrome was 2.03                                                                                                   Not adjusted

Abbreviations: BHS, Bogalusa Heart Study; BO, Boyd Orr Cohort; CI, confidence intervals; HR, hazard ratios; MCBPS, Minneapolis Children\'s Blood Pressure Study; MS, Muscatine Study; NTFS, Newcastle Thousand Families Cohort; NA, not applicable; NS, not significant; OR, odds ratios; s.d., standard deviation.

Although age 19 is outside the childhood age criteria, the authors report that when the data were broken down into 14--16 and 17--19, there were no differences between them and the overall findings.

Tracking not reported in this study. However, this figure is from the same Bogalusa cohort as reported by Freeman *et al.*^[@bib19]^

^\*^*P*\<0.05.

^\*\*^*P*\<0.001.

^\*\*\*^*P*\<0.01.

###### Assessment of quality for a cohort study (adapted from Newcastle--Ottawa Scale)

  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------
  Selection       
                  Representativeness of the intervention cohort:
                   • *truly representative of children in the contemporary western world*
                     *somewhat representative of children in the contemporary western world*
                   • selected group of patients, for example, only certain socioeconomic groups/areas
                   • no description of the derivation of the cohort
                  Selection of the non-intervention cohort (in this case 'normal weight\' during childhood):
                   • *drawn from the same community as the intervention cohort* (in this case 'at risk of overweight\' or 'overweight/obese\' during childhood)
                   • drawn from a different source
                   • no description of the derivation of the non-intervention cohort
                  Ascertainment of exposure:
                   • *measurement by trained health professional*
                     *secure record*
                   • written self-report
                   • other/no description
                  Demonstration that outcome of interest was not present at the start of study:
                   • *yes*
                   • no
                   
  Comparability   
                  Comparability of cohorts on the basis of the design or analysis:
                   • *study controls for age, sex and adult BM/percentage body fat*
                   • *study controls for socioeconomic status*
                   
  Outcome         
                  Assessment of outcome:
                   • *independent assessment by trained health-care professional*
                     *record linkage*
                   • self-report
                   • other/no description
                  Was follow-up long enough for outcomes to occur:
                   • *yes, if mean adult age \>35*
                   • no, if mean adult age ⩽35
                  Adequacy of follow-up of cohorts:
                   • *complete follow-up: all subjects accounted for*
                     *subjects lost to follow-up unlikely to introduce bias: number lost ≤20%, or description of those lost suggesting no different from those followed*
                   • follow-up rate \<80% and no description of those lost
                   • no statement
  --------------- --------------------------------------------------------------------------------------------------------------------------------------------------------

Stars were awarded if the criteria shown in italics were met.

###### Summary of results and quality scores

  *References*                          *Effect*     *Adjusted effect*   *Newcastle*--*Ottawa Scale*           
  ---------------------------------- -------------- ------------------- ----------------------------- -------- ----------
  *Total cholesterol*                                                                                          
   Freedman *et al.*^[@bib19]^             \+                −                    ^\*\*\*^              ^\*^     ^\*\*^
   Lauer *et al.*^[@bib23]^                \+          Not adjusted               ^\*\*\*^              ^\*^     ^\*\*^
   Sinaiko *et al.*^[@bib24]^              ↔           Not adjusted               ^\*\*\*^                       ^\*\*^
   Wright *et* *al*.^[@bib20]^            −, ↔             −, ↔                   ^\*\*\*^              ^\*^    ^\*\*\*^
                                                                                                                    
  *LDL cholesterol*                                                                                            
   Freedman *et al.*^[@bib19]^             \+                −                    ^\*\*\*^              ^\*^     ^\*\*^
   Sinaiko *et al.*^[@bib24]^              ↔           Not adjusted               ^\*\*\*^                       ^\*\*^
   Wright *et* *al*.^[@bib20]^             ↔                 ↔                    ^\*\*\*^              ^\*^    ^\*\*\*^
                                                                                                                    
  *HDL cholesterol*                                                                                            
   Freedman *et al.*^[@bib19]^             −                \+                    ^\*\*\*^              ^\*^     ^\*\*^
   Salonen *et al.*^[@bib17]^              ↔           Not reported               ^\*\*\*^             ^\*\*^    ^\*\*^
   Sinaiko *et al.*^[@bib24]^              −           Not adjusted               ^\*\*\*^                       ^\*\*^
   Wright *et* *al*.^[@bib20]^             ↔                 ↔                    ^\*\*\*^              ^\*^    ^\*\*\*^
                                                                                                                    
  *Triglycerides*                                                                                              
   Freedman *et al.*^[@bib19]^             \+                −                    ^\*\*\*^              ^\*^     ^\*\*^
   Salonen *et al.*^[@bib17]^              ↔           Not reported               ^\*\*\*^             ^\*\*^    ^\*\*^
   Sinaiko *et al.*^[@bib24]^              \+          Not adjusted               ^\*\*\*^                       ^\*\*^
   Wright *et* *al*.^[@bib20]^            −, ↔             −, ↔                   ^\*\*\*^              ^\*^    ^\*\*\*^
                                                                                                                    
  *Insulin*                                                                                                    
   Freedman *et al.*^[@bib19]^             \+                −                    ^\*\*\*^              ^\*^     ^\*\*^
   Freedman *et al.*^[@bib18]^             \+         Not adjusted^a^             ^\*\*\*^              ^a^      ^\*\*^
   Martin *et al.*^[@bib21]^              −^b^         Not adjusted               ^\*\*\*^              ^\*^    ^\*\*\*^
   Thearle *et al.*^[@bib16]^         Not reported      −^c^, +^d^                 ^\*\*^               ^\*^     ^\*\*^
   Sinaiko *et al.*^[@bib24]^              \+          Not adjusted               ^\*\*\*^                       ^\*\*^
   Wright *et* *al*.^[@bib20]^             ↔                 −                    ^\*\*\*^              ^\*^    ^\*\*\*^
                                                                                                                    
  *Disease outcomes*                                                                                           
   Bjørge *et al.*^[@bib22]^               ↔           Not adjusted               ^\*\*\*^                      ^\*\*\*^
   Morrison *et al.*^[@bib28]^             \+          Not adjusted               ^\*\*\*^                      ^\*\*\*^
   Salonen *et al.*^[@bib17]^              −                 −                    ^\*\*\*^             ^\*\*^    ^\*\*^
   Srinivasan *et* *al*.^[@bib15]^         \+          Not adjusted              ^\*\*\*\*^             ^\*^     ^\*\*^

Abbreviations: HDL, high-density lipoprotein; HOMA, homeostasis model assessment; LDL, low-density lipoprotein.

+, positive correlation; ↔, no significant correlation; −, negative correlation; multiple annotations reflect differing associations found within paper, for example, at different age groups; ^a^not reported; ^b^HOMA insulin resistance; ^c^insulin action; ^d^acute insulin response. Stars (^\*^) were awarded for selection, comparability and assessment according to the criteria in [Table 2](#tbl2){ref-type="table"}.
